444 related articles for article (PubMed ID: 1805332)
21. Antibodies to ribosomal ribonucleoprotein. Prevalence in systemic rheumatic diseases and partial characterization of the antigen.
Cortés JJ; Mendoza F; Reyes PA
J Rheumatol; 1987 Aug; 14(4):727-31. PubMed ID: 3118019
[TBL] [Abstract][Full Text] [Related]
22. The autoimmune diseases.
Kohler PF; Vaughan J
JAMA; 1982 Nov; 248(20):2646-57. PubMed ID: 7143627
[No Abstract] [Full Text] [Related]
23. [Antinuclear antibodies, anti-SSA(Ro) and SSB(La) in diffuse connective tissue diseases].
Assad RL; Gabriel Júnior A; Iglesias SS; Cossermelli W
Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(3):103-8. PubMed ID: 3551017
[No Abstract] [Full Text] [Related]
24. The autoimmune diseases.
Condemi JJ
JAMA; 1987 Nov; 258(20):2920-9. PubMed ID: 3312676
[No Abstract] [Full Text] [Related]
25. Autoantibodies and the autoimmune diseases.
Josephson AS
Bull N Y Acad Med; 1981 Sep; 57(7):631-7. PubMed ID: 6974027
[No Abstract] [Full Text] [Related]
26. [Diffuse connective tissue diseases (DCTD)--a review].
Steinsson K; Erlendsson K
Nord Med; 1994; 109(8-9):231-5. PubMed ID: 7937032
[TBL] [Abstract][Full Text] [Related]
27. Viruses and autoimmune disease.
Vaughan JH
J Rheumatol; 1996 Nov; 23(11):1831-3. PubMed ID: 8923350
[No Abstract] [Full Text] [Related]
28. [Experimental models of systemic scleroderma].
Serakovski S; Kukhazh E; Bernatska K
Revmatologiia (Mosk); 1989; (3):36-46. PubMed ID: 2692123
[No Abstract] [Full Text] [Related]
29. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
Levo Y; Lotan C
Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
[No Abstract] [Full Text] [Related]
30. Consideration of pathogenesis of rheumatoid arthritis as collagen autoimmunity.
Steffen C
Z Immunitatsforsch Allerg Klin Immunol; 1970 Apr; 139(3):219-27. PubMed ID: 4250050
[No Abstract] [Full Text] [Related]
31. Autonomic dysfunction in autoimmune diseases: consequence or cause?
Mravec B
Lupus; 2007; 16(9):767-8. PubMed ID: 17728374
[No Abstract] [Full Text] [Related]
32. [Significance of antibodies against intermediate filaments in rheumatoid polyarthritis, chronic inflammatory rheumatism and connective tissue diseases].
Fabregas-Canales D; Meyer O; Haim T; Kuntz D
Rev Rhum Mal Osteoartic; 1989 Jan; 56(1):45-50. PubMed ID: 2471252
[No Abstract] [Full Text] [Related]
33. Anti-SSB/La antibodies in Sjögren's syndrome and related autoimmune diseases. Results of a quantitative immunoassay using a highly purified antigen.
Montecucco C; Bestagno M; Cerino A; Caporali R; Carnevale R; Longhi M; Pedrini MA; Astaldi-Ricotti GC
Clin Exp Rheumatol; 1989; 7(1):5-11. PubMed ID: 2495873
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of mouse models to study the pathogenesis of Sjögren's syndrome.
Soyfoo MS; Steinfeld S; Delporte C
Oral Dis; 2007 Jul; 13(4):366-75. PubMed ID: 17577322
[TBL] [Abstract][Full Text] [Related]
35. Testing for autoimmunity in humans.
D'Cruz D
Toxicol Lett; 2002 Feb; 127(1-3):93-100. PubMed ID: 12052646
[TBL] [Abstract][Full Text] [Related]
36. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
37. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
38. The connective tissue diseases and the overall influence of gender.
Lahita RG
Int J Fertil Menopausal Stud; 1996; 41(2):156-65. PubMed ID: 8829695
[TBL] [Abstract][Full Text] [Related]
39. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases.
Ramos-Casals M; Jara LJ; Medina F; Rosas J; Calvo-Alen J; Mañá J; Anaya JM; Font J;
J Intern Med; 2005 Jun; 257(6):549-57. PubMed ID: 15910559
[TBL] [Abstract][Full Text] [Related]
40. Systemic lupus erythematosus and Sjögren's syndrome induced in a case by interferon-alpha used for the treatment of hepatitis C.
Onishi S; Nagashima T; Kimura H; Matsuyama Y; Yoshio T; Minota S
Lupus; 2010 May; 19(6):753-5. PubMed ID: 20064909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
